Video
Video
11/20/2024
Gautam Dantas, PhD
In this video, Gautam Dantas, PhD, discusses the results of his study, which showed that altered gut bacteria may be an indicator of the earliest stages of Alzheimer disease. He also talks about whether...
11/20/2024
Video
Video
11/12/2024
Paul B. Rosenberg, MD
In this video, Paul B. Rosenberg, MD, discusses his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. The study found that dronabinol...
11/12/2024
Video
Video
08/29/2024
In this video, Kasia Rothenberg, MD, PhD, describes Alzheimer disease-related agitation, details the difficulty in testing for Alzheimer disease-related agitation, looks ahead to potential treatment options...
08/29/2024
expert Q&A
expert Q&A
05/31/2024

Joseph Magagnoli, MS

Joseph Magagnoli, MS
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
05/31/2024
Video
Video
05/07/2024

Alex Martinez

Alex Martinez
In this video, Alex Martinez discusses research on the use of human milk oligosaccharides (HMOs) in the prevention and treatment of nervous system diseases, such as Alzheimer disease, including the...
05/07/2024
Conference Coverage
Conference Coverage
04/19/2024
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
04/19/2024
Video
Video
04/14/2024
Samar R. El Khoudary, PhD, MPH, BPharm, FAHA
In a long-term follow-up study, Samar R. El Khoudary, PhD, MPH, BPharm, FAHA, and colleagues investigated how the quantity and quality of cardiovascular fat in women with Alzheimer disease measured during...
04/14/2024
expert Q&A
expert Q&A
04/13/2024

James W. Antoon, MD, PhD, MPH

James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
Video
Video
03/25/2024
Brenden P. Lucy, MD
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024